Home › Funds › Deep Track Capital, LP › OCUL

Deep Track Capital, LP position in OCUL

OCULAR THERAPEUTIX INC · Health Care

Deep Track Capital, LP reported holding 19,686,282 shares of OCUL (OCULAR THERAPEUTIX INC) in its Q2 2026 13F filing — a position valued at US$193.3M, representing 2.88% of its reported portfolio and ranking #10 among its reported holdings. Deep Track Capital, LP has disclosed OCUL holdings in 11 of the last 11 reported quarters, going back to Q4 2023.

Latest position (Q2 2026)19.69M sh
Reported value held$193.32M
Portfolio Weight2.88%
First reportedQ4 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Deep Track Capital, LP's OCUL position evolved

Deep Track Capital, LP first disclosed a stake in OCUL in Q4 2023 at 9,230,769 shares (US$41.2M). The position peaked in Q2 2026 at 19,686,282 shares, worth US$193.3M. Across 11 filings, Deep Track Capital, LP increased the stake 4 time(s), trimmed it 2 time(s) and left it unchanged 4 time(s). The most recent filing (Q2 2026) shows 19,686,282 shares valued at US$193.3M. Notable position changes include a 38% increase in Q1 2024 (shares fell 25% over the following quarter), a 32% trim in Q4 2025 (shares fell 30% over the following quarter), a 144% increase in Q1 2026 (shares rose 16% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 9.23M $41.17M New
Q1 2024 12.72M $115.77M Add
Q2 2024 12.72M $87.01M Hold
Q3 2024 12.72M $110.68M Hold
Q4 2024 12.84M $109.62M Add
Q1 2025 14.29M $104.78M Add
Q2 2025 14.29M $132.65M Hold
Q3 2025 11.93M $139.49M Reduce
Q4 2025 8.07M $97.97M Reduce
Q1 2026 19.69M $166.74M Add
Q2 2026 19.69M $193.32M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About OCUL and 13F data

OCUL (OCULAR THERAPEUTIX INC) is a Health Care company. 42 other funds we track also report a position in OCUL — the largest reported positions include Avoro Capital Advisors LLC (US$123.1M), SUMMER ROAD LLC (US$119.9M), Venrock Adviser, LLC (US$101.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding OCUL

All OCUL fund holders →

FAQ

How long has Deep Track Capital, LP held OCUL?

Deep Track Capital, LP has disclosed OCUL holdings in 11 of the last 11 reported quarters, going back to Q4 2023.

What is Deep Track Capital, LP's current position in OCUL?

As of Q2 2026, Deep Track Capital, LP holds 19.69M shares of OCUL (OCULAR THERAPEUTIX INC), valued at $193.32M, representing 2.88% of its reported portfolio and ranking #10.

Has Deep Track Capital, LP been buying or selling OCUL?

In the latest 13F filing (Q2 2026), Deep Track Capital, LP held unchanged its position in OCUL. The position peaked in Q2 2026 at 19.69M shares.

Which other funds hold OCUL?

Other major institutional holders of OCUL include Avoro Capital Advisors LLC, SUMMER ROAD LLC, Venrock Adviser, LLC, among 42 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.